NCT02266069

Brief Summary

It is important to provide high quality palliative care to all patients with a non-curable and life-limiting condition. The Care Pathway for Primary Palliative Care (CPPPC) provides tools for health care professionals to help them delivering palliative care timely and accurately.This study investigates whether the implementation of the CPPPC really helps to improve patients' lifes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2014

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

October 10, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 16, 2014

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

November 29, 2017

Status Verified

November 1, 2017

Enrollment Period

2.2 years

First QC Date

October 10, 2014

Last Update Submit

November 27, 2017

Conditions

Keywords

implementationanticipatory care planningsymptom assessmentinterdisciplinary collaboration

Outcome Measures

Primary Outcomes (1)

  • percentage of deaths occurred in the hospital (of patients per family doctor/per research cluster)

    The hypothesis is that the CPPPC reduces the percentage of deaths occurred in the hospital

    6 months

Secondary Outcomes (4)

  • cost of health care consumption in the last year of life (of patients per family doctor/per research cluster)

    6 months

  • consumption of antibiotics in the last year of life (of patients per family doctor/per research cluster)

    6 months

  • consumption of pain killers in the last year of life (of patients per family doctor/per research cluster)

    6 months

  • consumption of (invasive) diagnostic and therapeutic procedures in the last year of life (of patients per family doctor/per research cluster)

    6 months

Study Arms (5)

Research cluster 1: Antwerp

OTHER

The first Dutch-speaking research cluster in a stepped wedge cluster design. Family doctors are implementing the Care Pathway for Primary Palliative Care and will recruit eligible patients from October 2014.

Other: Care Pathway for Primary Palliative Care

Research cluster 2: Mons

OTHER

The first French-speaking research cluster in a stepped wedge cluster design. Family doctors are implementing the Care Pathway for Primary Palliative Care and will recruit eligible patients from November 2014.

Other: Care Pathway for Primary Palliative Care

Research cluster 3: Brussels

OTHER

The only bilingual Dutch/French-speaking research cluster in a stepped wedge cluster design. Family doctors are implementing the Care Pathway for Primary Palliative Care and will recruit eligible patients from December 2014.

Other: Care Pathway for Primary Palliative Care

Research cluster 4: Limburg

OTHER

The second Dutch-speaking research cluster in a stepped wedge cluster design. Family doctors will implement the Care Pathway for Primary Palliative Care and will recruit eligible patients from April 2015.

Other: Care Pathway for Primary Palliative Care

Research cluster 5: ?

OTHER

A second French-speaking research cluster in a stepped wedge cluster design. Family doctors will implement the Care Pathway for Primary Palliative Care and will recruit eligible patients from October 2015.

Other: Care Pathway for Primary Palliative Care

Interventions

Early identification of palliative care patients, anticipatory care planning, systematic symptom assessment, interdisciplinary collaboration, rigorous follow-up of the functional status of the patient and giving attention to the informal care givers.

Also known as: CPPPC
Research cluster 1: AntwerpResearch cluster 2: MonsResearch cluster 3: BrusselsResearch cluster 4: LimburgResearch cluster 5: ?

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • identified as a palliative care patient using the Surprise Question "Would you, as a family doctor, be surprised if this patient would die in the next 12 months?". If the answer is 'no', the patient is eligible for the study.

You may not qualify if:

  • not having signed the informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Reliance

Mons, Hainaut, Belgium

Location

Netwerk Palliatieve Zorg Limburg

Hasselt, Limburg, Belgium

Location

Palliatieve Hulpverlening Antwerpen

Antwerp, Belgium

Location

Palliabru

Brussels-Capital Region, Belgium

Location

Related Publications (2)

  • Leysen B, Van den Eynden B, Janssens A, Wens J. Recruiting general practitioners for palliative care research in primary care: real-life barriers explained. BMC Fam Pract. 2019 Mar 5;20(1):40. doi: 10.1186/s12875-019-0930-y.

  • Leysen B, Van den Eynden B, Gielen B, Bastiaens H, Wens J. Implementation of a Care Pathway for Primary Palliative Care in 5 research clusters in Belgium: quasi-experimental study protocol and innovations in data collection (pro-SPINOZA). BMC Palliat Care. 2015 Sep 28;14:46. doi: 10.1186/s12904-015-0043-x.

Related Links

MeSH Terms

Interventions

Critical Pathways

Intervention Hierarchy (Ancestors)

Patient Care PlanningComprehensive Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Bart Van den Eynden, MD, PhD

    Universiteit Antwerpen

    PRINCIPAL INVESTIGATOR
  • Johan Wens, MD, PhD

    Universiteit Antwerpen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, PhD candidate

Study Record Dates

First Submitted

October 10, 2014

First Posted

October 16, 2014

Study Start

October 1, 2014

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

November 29, 2017

Record last verified: 2017-11

Locations